resveratrol has been researched along with Autoimmune Diabetes in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 18 (64.29) | 24.3611 |
| 2020's | 9 (32.14) | 2.80 |
| Authors | Studies |
|---|---|
| Che, K; Chi, J; Fu, Z; Hu, J; Liu, X; Ma, X; Qiu, M; Wang, W; Wang, Y | 1 |
| Elswefy, SE; Hammad, SK; Khalil, SG; Shaheen, MA; Younis, NN | 1 |
| Kalantarhormozi, M; Mahmoodi, M; Movahed, A; Nabipour, I; Netticadan, T; Ostovar, A; Raj, P | 1 |
| Chi, J; Gao, Y; Hu, J; Lv, W; Ma, X; Wang, W; Wang, Y; Xian, Y | 1 |
| Chen, Z; Gong, D; Liu, X; Wang, L; Yang, Y; Zhang, J | 1 |
| Fischer, LW; Mendes, TB; Miraglia, SM; Simas, JN; Vendramini, V | 1 |
| Abdel-Bakky, MS; Abo-Saif, AA; Abo-Youssef, AM; Darwish, MA; Messiha, BAS | 2 |
| Al-Hussaini, H; Kilarkaje, N; Kittaneh, RS | 1 |
| Bai, L; Cai, L; Cui, J; Jin, X; Li, Y; Song, W; Wang, Z; Xu, J; Zhao, Y | 1 |
| Al-Hussaini, H; Kilarkaje, N | 2 |
| Mendes, TB; Miraglia, SM; Paccola, CC; Simas, JN; Vendramini, V | 1 |
| Li, Z; Liu, B; Song, X; Wang, G; Zhao, L | 1 |
| Alves-Wagner, AB; Correa-Giannella, ML; Esteves, JV; Giannella-Neto, D; Machado, UF; Okamoto, MM; Yonamine, CY | 1 |
| Dipette, DJ; Kumar, A; Lavoie, HA; Singh, CK; Singh, US | 1 |
| Alidori, A; Borroni, F; Faloia, E; Giulietti, A; Mazzanti, L; Nanetti, L; Raffaelli, F; Sforza, G; Vignini, A | 1 |
| Bocchi, L; Bresciani, L; Brighenti, F; Calani, L; Del Rio, D; Delucchi, F; Ray, S; Savi, M; Stilli, D | 1 |
| Aktaş, A; Atamer, Y; Deveci, E; Ezel, T; Kocyigit, Y; Sermet, A; Uysal, E; Yavuz, D | 1 |
| Abdelali, A; Al-Bader, M; Kilarkaje, N | 1 |
| Abraham, NG; Drummond, G; Falck, JR; Peterson, SJ; Rezzani, R; Rodella, LF; Vanella, L | 1 |
| Akar, F; Gokalp, B; Ozturk, K; Pektas, MB; Sepici, A; Soylemez, S; Surucu, HS; Tufan, C; Ulus, AT | 1 |
| Csiszar, A; Ungvari, Z | 1 |
| Fang, D; Gao, B; Lee, SM; Luo, X; Tartar, DM; Yang, H; Ye, SQ; Zaghouani, H | 1 |
| Arrick, DM; Mayhan, WG; Patel, KP; Sun, H | 1 |
| Chien, A; Devaraj, S; Jialal, I; Yun, JM | 1 |
| Kim, SK; Ku, CR; Lee, EJ; Lee, EY; Lee, HJ; Lee, MK | 1 |
| Berni, R; Bocchi, L; Calani, L; Cavalli, S; Chaponnier, C; Del Rio, D; Delucchi, F; Frati, C; Gabbiani, G; Graiani, G; Lagrasta, C; Quaini, F; Sala, R; Stilli, D | 1 |
1 review(s) available for resveratrol and Autoimmune Diabetes
| Article | Year |
|---|---|
Diabetic complications in pregnancy: is resveratrol a solution?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Complications; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Humans; Hypoglycemic Agents; Pregnancy; Pregnancy in Diabetics; Resveratrol; Stilbenes | 2013 |
1 trial(s) available for resveratrol and Autoimmune Diabetes
| Article | Year |
|---|---|
Efficacy and Safety of Resveratrol in Type 1 Diabetes Patients: A Two-Month Preliminary Exploratory Trial.
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Blood Glucose; Child; Diabetes Mellitus, Type 1; Dietary Supplements; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Kidney; Liver; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Plant Extracts; Plants, Edible; Resveratrol; Young Adult | 2020 |
26 other study(ies) available for resveratrol and Autoimmune Diabetes
| Article | Year |
|---|---|
Resveratrol Enhances Wound Healing in Type 1 Diabetes Mellitus by Promoting the Expression of Extracellular Vesicle-Carried MicroRNA-129 Derived from Mesenchymal Stem Cells.
Topics: Animals; Diabetes Mellitus, Type 1; Extracellular Vesicles; Human Umbilical Vein Endothelial Cells; Humans; Mesenchymal Stem Cells; MicroRNAs; Rats; Resveratrol; Wound Healing | 2022 |
Evaluation of in vivo and ex vivo pre-treated bone marrow-derived mesenchymal stem cells with resveratrol in streptozotocin-induced type 1 diabetic rats.
Topics: Animals; Bone Marrow; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Insulin; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Resveratrol; Streptozocin | 2023 |
Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Inflammation; Memory Disorders; Mice; Mice, Inbred NOD; Resveratrol | 2020 |
Inhibition of the SIRT1 signaling pathway exacerbates endoplasmic reticulum stress induced by renal ischemia/reperfusion injury in type 1 diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endoplasmic Reticulum Stress; Kidney; Kidney Function Tests; Male; Pyroptosis; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Signal Transduction; Sirtuin 1 | 2020 |
Resveratrol improves sperm DNA quality and reproductive capacity in type 1 diabetes.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; DNA Fragmentation; Drug Evaluation, Preclinical; Infertility, Male; Lipid Peroxidation; Male; Rats, Wistar; Reproduction; Resveratrol; Spermatozoa | 2021 |
Resveratrol inhibits macrophage infiltration of pancreatic islets in streptozotocin-induced type 1 diabetic mice via attenuation of the CXCL16/NF-κΒ p65 signaling pathway.
Topics: Animals; Chemokine CXCL16; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Islets of Langerhans; Macrophages; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Resveratrol; Signal Transduction; Streptozocin; Transcription Factor RelA | 2021 |
Resveratrol mitigates pancreatic TF activation and autophagy-mediated beta cell death via inhibition of CXCL16/ox-LDL pathway: A novel protective mechanism against type 1 diabetes mellitus in mice.
Topics: Animals; Antioxidants; Autophagy; Cell Death; Chemokine CXCL16; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Insulin-Secreting Cells; Lipoproteins, LDL; Male; Mice; Mice, Inbred BALB C; Protective Agents; Resveratrol; Signal Transduction; Thromboplastin | 2021 |
Effects of trans-resveratrol on type 1 diabetes-induced up-regulation of apoptosis and mitogen-activated protein kinase signaling in retinal pigment epithelium of Dark Agouti rats.
Topics: Aldehydes; Animals; Antigens, Bacterial; Apoptosis; Bacterial Toxins; Blood Glucose; Body Weight; Caspase 3; Caspase 8; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Rats; Resveratrol; Retinal Pigment Epithelium; Streptozocin; Up-Regulation | 2021 |
Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation.
Topics: Animals; Antioxidants; Apoptosis; Diabetes Mellitus, Type 1; Kelch-Like ECH-Associated Protein 1; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Proteolysis; Proto-Oncogene Proteins c-akt; Resveratrol; Sequestosome-1 Protein; Stilbenes; Testis | 2018 |
Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
Topics: Animals; Antioxidants; Diabetes Mellitus, Type 1; DNA Damage; Glycation End Products, Advanced; Kidney Glomerulus; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2018 |
Resveratrol attenuates reproductive alterations in type 1 diabetes-induced rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Epididymis; Male; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Reproduction; Resveratrol; Sperm Motility; Spermatozoa; Stilbenes; Testis | 2017 |
Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Gene Expression Regulation; Male; Mice; NF-E2-Related Factor 2; Resveratrol; Stilbenes; Transcription, Genetic | 2018 |
Effects of trans-resveratrol on type 1 diabetes-induced inhibition of retinoic acid metabolism pathway in retinal pigment epithelium of Dark Agouti rats.
Topics: Alcohol Oxidoreductases; Animals; Diabetes Mellitus, Type 1; Enzyme Induction; Gene Expression Regulation; Male; Rats; Resveratrol; Retinal Pigment Epithelium; Retinoic Acid 4-Hydroxylase; Time Factors; Tretinoin | 2018 |
Diabetes induces tri-methylation at lysine 9 of histone 3 at Slc2a4 gene in skeletal muscle: A new target to improve glycemic control.
Topics: Animals; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Epigenesis, Genetic; Glucose Transporter Type 4; Histones; Humans; Insulin; Lysine; Male; Methylation; Mice; Muscle, Skeletal; Promoter Regions, Genetic; Rats; Resveratrol | 2019 |
In vitro effects of resveratrol on oxidative stress in diabetic platelets.
Topics: Adult; Aged; Antioxidants; Blood Platelets; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Membrane Fluidity; Middle Aged; Oxidative Stress; Resveratrol; Stilbenes | 2014 |
Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.
Topics: Animals; Biotransformation; Blood Glucose; Body Weight; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Glucuronides; Heart Diseases; Hemodynamics; Male; Myocardium; Rats, Wistar; Resveratrol; Stilbenes; Sulfates; Time Factors | 2014 |
Biochemical and Histopathological Investigation of Resveratrol, Gliclazide, and Losartan Protective Effects on Renal Damage in a Diabetic Rat Model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Gliclazide; Hypoglycemic Agents; Immunohistochemistry; Kidney; Losartan; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2015 |
Effects of Trans-Resveratrol on hyperglycemia-induced abnormal spermatogenesis, DNA damage and alterations in poly (ADP-ribose) polymerase signaling in rat testis.
Topics: Animals; Diabetes Mellitus, Type 1; DNA Damage; Hyperglycemia; Male; Oxidation-Reduction; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Spermatogenesis; Spermatozoa; Stilbenes; Testis | 2016 |
Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes.
Topics: Adiponectin; Animals; Aorta; Carbon Monoxide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelial Cells; Enzyme Induction; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Male; Organometallic Compounds; Protoporphyrins; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin | 2008 |
Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.
Topics: Acetylcholine; Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Estrogens; Insulin; Lipid Peroxides; Lipids; Male; NADP; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rabbits; Resveratrol; Stilbenes; Superoxide Dismutase; Testosterone; Time Factors; Vascular Diseases | 2011 |
Resveratrol confers endothelial protection in insulin-dependent diabetes mellitus: editorial to: "Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits" by F. Ak
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Male; Oxidative Stress; Resveratrol; Stilbenes; Vascular Diseases | 2011 |
Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.
Topics: Animals; Cell Movement; Cells, Cultured; Chemokine CCL20; Diabetes Mellitus, Type 1; Female; Flow Cytometry; Hypoglycemic Agents; Interleukin-17; Mice; Mice, Inbred NOD; Receptors, CCR6; Resveratrol; Stilbenes | 2011 |
Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats.
Topics: Analysis of Variance; Animals; Antioxidants; Arterioles; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dose-Response Relationship, Drug; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Pia Mater; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides; Vasodilation; Vasodilator Agents | 2011 |
Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.
Topics: Antioxidants; Cell Line; Diabetes Mellitus, Type 1; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Mitochondria; Monocytes; NADPH Oxidases; Oxidative Stress; Resveratrol; RNA, Small Interfering; Sirtuin 1; Stilbenes; Superoxides; Up-Regulation | 2012 |
Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Caspase 3; Diabetes Mellitus, Type 1; Enzyme Activation; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin-Secreting Cells; Male; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteolysis; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin; Time Factors | 2012 |
Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats.
Topics: Actins; Animals; Apoptosis; Blood Glucose; Body Weight; Calcium Signaling; Cell Count; Coculture Techniques; Diabetes Mellitus, Type 1; Endothelial Cells; Hemodynamics; HMGB1 Protein; Intracellular Space; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Resveratrol; Stem Cells; Stilbenes; Ventricular Remodeling | 2012 |